Sort   by:  
 Page size 
UnknownGrowth/differentiation factor 15 controls ependymal and stem cell number in the V-SVZ.
Not available
S-EPMC10937156 | biostudies-literature
UnknownThe association between adverse events and outcome under checkpoint inhibitors: Where is the deal?
Not available
S-EPMC7708939 | biostudies-literature
UnknownPharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective.
Not available
S-EPMC4921117 | biostudies-literature
UnknownUnraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology.
Not available
S-EPMC7981594 | biostudies-literature
UnknownLike a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy.
Not available
S-EPMC7464249 | biostudies-literature
UnknownClinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors.
Not available
S-EPMC6584248 | biostudies-literature
UnknownImpact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping.
Not available
S-EPMC10265596 | biostudies-literature
UnknownKilling a fly with a sledgehammer: Atezolizumab exposure in real-world lung cancer patients.
Not available
S-EPMC10681534 | biostudies-literature
UnknownOvercoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model.
Not available
S-EPMC10951825 | biostudies-literature
UnknownAntiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression.
Not available
S-EPMC2634969 | biostudies-literature
Sort   by:  
 Page size